Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron in male patients with diarrhea-predominant IBS
NCT00918411Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramosetron in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Astellas Pharma. Started Jun 2009; status: completed.
02
Drugs
ramosetron
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT00918411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918411.